The Motivation and Pleasure Scale–Self-Report (MAP-SR): Reliability and validity of a self-report measure of negative symptoms
Introduction
Negative symptoms of schizophrenia are associated with poor functional outcome and are only minimally responsive to antipsychotic medication. Research has shown that approximately 28% to 36% of individuals with schizophrenia show elevated negative symptoms [1], and they demonstrate worse social and community functioning compared to those with schizophrenia with lower levels of negative symptoms [1]. Such findings illustrate the critical importance of sound assessment of negative symptoms. The Clinical Assessment Interview for Negative Symptoms (CAINS) [2], [3], [4] was developed to address the limitations of existing measures of negative symptoms [2], [4], [5], [6], [7] by going beyond indicators of behavioral success (e.g., functional outcome). The CAINS offers unique contributions to assessment with its emphasis on individuals' internal experiences of motivation, drive, and interest; inclusion of clear descriptive anchor points; and provision of a comprehensive user's manual and training videos [2], [8]. Additionally, the CAINS has good convergent and discriminant validity and inter-rater reliability [8], [9] across its two factor-derived scales measuring deficits in motivation and pleasure (MAP) and expression (EXP).
There are many cases in which time precludes the use of an extended interview for the assessment of negative symptoms. A self-report measure would provide a time efficient method for the initial identification of people with elevated negative symptoms [10]. To this end, we sought to evaluate a self-report version of the CAINS. The two-factor structure of negative symptoms informed development, where one factor reflects deficits in motivation and pleasure (anhedonia, asociality, amotivation) and the other reflects expressive deficits (blunted affect andalogia). This factor structure has been identified in various clinical interviews [11], [12], [13] and has been replicated in recent studies of the CAINS [8], [9]. In a preliminary study, Park and colleagues [14] administered the CAINS-SR to 69 people with schizophrenia or schizoaffective disorder. The Experience Subscale (e.g., motivation, pleasure, asociality) showed good internal consistency, good convergent validity with the Experience domain of the CAINS, and good discriminant validity. The internal consistency and validity of the Expression subscale were less robust.
These findings led to further refinement of the self-report measure of negative symptoms. Due to poor reliability and validity, the Expression items were removed, yielding a revised measure that focuses exclusively on self-reported deficits in motivation and pleasure. Given this new focus, the measure was renamed the Motivation and Pleasure Scale–Self-Report (MAP-SR). Sharpening the focus of the measure should improve its utility as a self-report measure of negative symptoms since motivation and pleasure capture many of the core deficits of negative symptoms that are directly related to functional impairment [2].
The current study evaluated the psychometric properties of the MAP-SR in a sample of outpatients with schizophrenia and schizoaffective disorder. We examined internal consistency, convergent validity with the CAINS interview, and discriminant validity. We hypothesized that the MAP-SR would demonstrate (1) good internal consistency, (2) a significant positive correlation with the Motivation and Pleasure (MAP) scale of the clinician-rated CAINS, and (3) no significant correlations with clinician-rated depressive or psychotic symptoms. We also explored the relationship between the MAP-SR and other trait and functioning measures, including associations between the MAP-SR, self-reported traits of social anhedonia and social closeness, and clinician-rated functional capacity and community functioning. We also examined whether MAP-SR scores were related to gender and general cognitive ability.
Section snippets
Participants
Participants were individuals with schizophrenia (n = 33) or schizoaffective disorder (n = 4) who were recruited from outpatient clinics affiliated with the University of Maryland–Baltimore or the Baltimore Veterans Affairs Medical Center as part of a larger study investigating the psychometric properties of the CAINS. Individuals with schizoaffective disorder were included to ensure a full range of symptoms and to increase external validity by representing the population for which this instrument
Internal consistency
Cronbach's alpha for the 18-item version of the MAP-SR was α = 0.87. When item statistics were reviewed, items 8, 10, and 12 showed the lowest item-total correlations (−0.26, 0.34, and 0.20 respectively). As a result, these items were dropped from the scale; all remaining analyses were conducted using the remaining 15 items. The resulting 15-item version of the MAP-SR showed excellent internal consistency (Cronbach's α = 0.90).
Convergent and discriminant validity
Correlations between MAP-SR scores, CAINS ratings, and ratings of other
Discussion
The current study examined the reliability and validity of the MAP-SR, a self-report measure of deficits in motivation and pleasure that are prominent features of negative symptoms and represent the experiential deficits of this symptom domain. Excluding the assessment of the expression domain and focusing on MAP allow for the assessment of core deficits of negative symptoms that are most directly related to functional impairment [2]. Although the 18-item version of the MAP-SR demonstrated
Acknowledgment
The authors wish to gratefully acknowledge the PIs (Drs. Ann Kring, William Horan, and Raquel Gur) on the Collaboration to Advance Negative Symptom Assessment in Schizophrenia (CANSAS) who had a role in the larger project, which made this study possible. This work was supported by the National Institute of Mental Health (R01-MH082839, K02-MH079231, and T32-MH020075 to J.J.B.). Institutional and administrative support for this research was provided by the VISN 5 Mental Illness Research Education
References (37)
- et al.
Examining the latent structure of negative symptoms: is there a distinct subtype of negative symptom schizophrenia?
Schizophr Res
(2005) - et al.
Initial development and preliminary validation of a new negative symptom measure The Clinical Assessment Interview for Negative Symptoms (CAINS)
Schizophr Res
(2010) - et al.
Factor structure of the negative symptom assessment
Psychiatry Res
(1994) - et al.
Development and psychometric validation of the Clinical Assessment Interview for Negative Symptoms (CAINS)
Schizophr Res
(2011) - et al.
The positive and negative symptoms questionnaire: a self-report scale in schizophrenia
Compr Psychiatry
(2005) - et al.
Avolition and expressive deficits capture negative symptom phenomenology: implications for DSM-5 and schizophrenia research
Clin Psychol Rev
(2011) - et al.
Screening for negative symptoms: preliminary results from the self-report version of the Clinical Assessment Interview for Negative Symptoms
Schizophr Res
(2012) - et al.
A Depression Rating-Scale for schizophrenics
Schizophr Res
(1990) - et al.
Reliability and validity of a Depression Rating-Scale for schizophrenics
Schizophr Res
(1992) - et al.
Psychometric comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating Scale
Schizophr Res
(1996)
Depression in schizophrenia: a comparison of three measures
Schizophr Res
Diagnostic validity of assessment scales for depression in patients with schizophrenia
Psychiatry Res
Toward the next generation of negative symptom assessments: the collaboration to advance negative symptom assessment in schizophrenia
Schizophr Bull
Anhedonia in schizophrenia: a review of assessment strategies
Schizophr Bull
Treatment of schizophrenia negative symptoms: future prospects
Schizophr Bull
The NIMH-MATRICS consensus statement on negative symptoms
Schizophr Bull
The structure of negative symptoms within schizophrenia: implications for assessment
Schizophr Bull
Cited by (140)
Examining the influence of self-referential thinking on aberrant salience and jumping to conclusions bias in individuals with schizophrenia-spectrum disorders
2024, Journal of Behavior Therapy and Experimental PsychiatryBlinding integrity of dorsomedial prefrontal intermittent theta burst stimulation in depression
2023, International Journal of Clinical and Health PsychologyRelationships between childhood trauma and dimensional schizotypy: A network analysis and replication
2023, Asian Journal of PsychiatryAssociations Between Cognitive and Physical Effort–Based Decision Making in People With Schizophrenia and Healthy Control Subjects
2023, Biological Psychiatry: Cognitive Neuroscience and NeuroimagingNegative Symptom Inventory-Self-Report (NSI-SR): Initial development and validation
2023, Schizophrenia Research